Cost-effectiveness considerations in the treatment of essential thrombocythemia

被引：5
|
作者：
Golub, R
Adams, J
Dave, S
Bennett, CL
机构：
[1] Northwestern Univ, Fernberg Sch Med, Dept Med, Chicago, IL 60611 USA
[2] VA Chicago Healthcare Syst, Lakeside Div, Chicago, IL USA
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期
关键词：
D O I：
10.1053/sonc.2002.33758
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 32
页数：5
相关论文
共 50 条
  • [1] Anagrelide for treatment of essential thrombocythemia (ET): A cost-effectiveness analysis.
    Weinberg, PD
    Golub, RM
    Bennett, CL
    [J]. BLOOD, 1998, 92 (10) : 423A - 423A
  • [2] The cost-effectiveness of therapeutic options for essential thrombocythemia.
    Golub, RM
    Dave, S
    Adams, JR
    Bennett, CL
    [J]. BLOOD, 2001, 98 (11) : 426A - 426A
  • [3] Treatment with statins: cost-effectiveness considerations
    Verdecchia, Paolo
    [J]. GIORNALE ITALIANO DI CARDIOLOGIA, 2006, 7 (12) : 22S - 27S
  • [4] Cost-effectiveness considerations in otitis media treatment
    Gates, GA
    [J]. RECENT ADVANCES IN OTITIS MEDIA, 1996, : 1 - 4
  • [5] Cost-effectiveness considerations in otitis media treatment
    Gates, GA
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1996, 114 (04) : 525 - 530
  • [6] EFFECTIVENESS OF PIPOBROMAN IN THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA
    BAUTERS, F
    JOUET, JP
    SIMON, M
    POLLET, JP
    FENAUX, P
    WALTER, MP
    [J]. PRESSE MEDICALE, 1988, 17 (02): : 81 - 81
  • [7] AUTOTRANSFUSION - COST-EFFECTIVENESS CONSIDERATIONS
    ORR, MD
    BLENKO, J
    [J]. INTENSIVE CARE MEDICINE, 1977, 3 (03) : 215 - 215
  • [8] Cost-effectiveness considerations at NICE
    Rawlins, Michael
    Dillon, Andrew
    [J]. LANCET, 2008, 372 (9646): : 1302 - 1302
  • [9] COST-EFFECTIVENESS CONSIDERATIONS IN THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH MEDICATIONS
    GOLDMAN, L
    GOLDMAN, PA
    WILLIAMS, LW
    WEINSTEIN, MC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (10): : D75 - D79
  • [10] Remote Health Interventions: Effectiveness, Cost, and Cost-Effectiveness Considerations
    Williams, Austin M.
    Gift, Thomas L.
    [J]. SEXUALLY TRANSMITTED DISEASES, 2022, 49 (11S) : S15 - S17
12345